                         SEQUENCE LISTING

<110>  CEINGE BIOTECNOLOGIE AVANZATE SCARL
 
<120>  HUMAN NEUTRALIZING ANTIGEN SPECIFIC PROTEINS FOR SPIKE-RBD OF SARS-COV-2

<130>  1953PCT

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  117
<212>  PRT
<213>  Homo sapiens

<400>  1

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Thr Val Lys Ile Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Tyr Met His Trp Val Gln Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Leu Val Asp Pro Glu Asp Gly Glu Thr Ile Tyr Ala Glu Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ala Lys Ala Thr Leu Gly Leu Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Arg 
        115         


<210>  2
<211>  106
<212>  PRT
<213>  Homo sapiens

<400>  2

Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln Thr Val 
1               5                   10                  15      


Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala Ser Trp 
            20                  25                  30          


Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr Gly Lys 
        35                  40                  45              


Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser Ser Ser 
    50                  55                  60                  


Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu Asp Glu 
65                  70                  75                  80  


Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn His Val Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  3
<211>  355
<212>  DNA
<213>  Homo sapiens

<400>  3
ggcccaggtg cagctggtgc agtctggggc tgaggtgaag aagcctgggg ctacagtgaa       60

aatctcctgc aaggtttctg gatacacctt caccgactac tacatgcact gggtgcaaca      120

ggcccctgga aaagggcttg agtggatggg acttgttgat cctgaagatg gtgaaacaat      180

atacgcagag aagttccagg gcagagtcac cataaccgcg gacacgtcta cagacacagc      240

ctacatggag ctgagcagcc tgagatctga ggacacggcc gtgtattact gtgcaagagg      300

ggctaaggcg actctgggtt tgtggggcca aggtaccctg gtcaccgtgt cgaga           355


<210>  4
<211>  321
<212>  DNA
<213>  Homo sapiens

<400>  4
ctgagctgac tcaggaccct gctgtgtctg tggccttggg acagacagtc aggatcacat       60

gccaaggaga cagcctcaga agctattatg caagctggta ccagcagaag ccaggacagg      120

cccctgtact tgtcatctat ggtaaaaaca accggccctc agggatccca gaccgattct      180

ctggctccag ctcaggaaac acagcttcct tgaccatcac tggggctcag gcggaagatg      240

aggctgacta ttactgtaac tcccgggaca gcagtggtaa ccatgtggta ttcggcggag      300

ggaccaagct gaccgtccta g                                                321


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  5
gaccccaaaa tcagcgaaat                                                   20


<210>  6
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  6
tctggttact gccagttgaa tctg                                              24


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  7
gccactcacc tcttcagaac                                                   20


<210>  8
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  8
agcatccatc tttttcagcc                                                   20


<210>  9
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  9
cctgcctaac atgcttcgag a                                                 21


<210>  10
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  10
tgtccagctg atccttcatt tg                                                22


<210>  11
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  11
tgatggccct gtgccttagt                                                   20


<210>  12
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  12
ggatccatca gaagctttgc a                                                 21


<210>  13
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  13
aggcattttg aagaattgga aaga                                              24


<210>  14
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  14
agtaaaagga gacaatttgg ctct                                              24


<210>  15
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  15
tctctctaat cagccctctg g                                                 21


<210>  16
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  synthetic oligonucleotide

<400>  16
gctacatggg ctacaggc                                                     18


